Emphasis on Product (Syringes and Cannula); Usage (Reusable and Disposable); Distribution Channel (Hospitals, Diagnostic Laboratories, Skilled Nursing Facilities, and Others); Country
The MENA Syringes & Cannula market was valued at USD 1,505.79 million in 2023 and is expected to grow at a CAGR of 7.29% during the forecast period (2024-2032) due to the increasing healthcare expenditure and the rising prevalence of chronic diseases.
“Syringes & Cannula” refers to essential medical devices used primarily in healthcare settings for various purposes such as administering medications, withdrawing fluids, and collecting blood samples. Syringes are devices used to inject or withdraw fluids, consisting of a barrel, plunger, and needle. Cannula are flexible tubes inserted into veins or body cavities for administering medications or draining fluids, featuring a hub and sometimes wings for secure placement. This is mainly due to the increased healthcare budget to improve healthcare infrastructure and services, which directly increases the demand for medical devices, including syringes and cannula. Moreover, the rise in the prevalence of chronic diseases such as diabetes, which require regular administration of medication, often through injections, drives the demand for syringes. As per the International Diabetes Federation, in 2021, The Middle East and North Africa Region has the highest percentage (24.5%) of diabetes-related deaths in people of working age. Diabetes-related expenditure in the Middle East and North Africa Region’s total USD 33 billion in 2021.
This section discusses the key market trends that are influencing the various segments of the MENA Syringes & Cannula market, as identified by our team of research experts.
Hospitals Transforming Industry
Hospitals held the largest market share in 2023. The surge in chronic diseases is boosting the demand for these medical consumables in hospital settings. The GCC has over 829 hospitals, accommodating more than 119,679 beds as of 2020, in addition to many primary healthcare centers, medical clinics, and laboratories, as per the Health Ministries of GCC countries. Moreover, the push towards improving healthcare quality standards in the region encourages hospitals to use advanced, disposable syringes and cannulas to ensure patient safety and prevent cross-contamination.
Saudi Arabia dominate the market in 2023
Saudi Arabia held a dominant share of the market in 2023. The increasing focus on preventive care and managing chronic diseases, such as diabetes, necessitates a reliable supply of these disposables to support ongoing medical treatments and vaccinations, further driving the market’s growth. For instance, in February 2022, according to an article published by the American Society of Clinical Oncology Journal, more than 436 million people in the Middle East and North Africa region have cancer, with men making up 51.8% of those cases and women making up the remaining 48.2% in Saudi Arabia. New cancer cases were 463,675 in total, corresponding to 2.4% of the global incident cases, and males’ cancers accounted for 47.3% of that number, compared with 52.7% globally. Moreover, Saudi has a large healthcare budget and extensive healthcare modernization initiatives. A corresponding increase in the demand for medical supplies, including syringes and cannula accompanies this infrastructure development.
The MENA Syringes & Cannula market is competitive and fragmented, with the presence of several MENA and international market players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, and mergers and acquisitions. Some of the major players operating in the market are BD, Terumo Europe NV, Thermo Fisher Scientific Inc., Nipro Europe Group Companies, Medtronic, B. Braun SE, Henke-Sass, Wolf GmbH, Hindustan Syringes & Medical Devices Ltd, Cardinal Health, Medline Industries, LP.
Reasons to buy this report:
Customization Options:
The MENA Syringes & Cannula market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
1. Market Introduction
2. Research Methodology Or Assumption
3. Executive Summary
4. Market Dynamics
5. Pricing Analysis
6. Mena Syringes & Cannula Market Revenue (usd Mn), 2022-2032f
7. Market Insights By Product
8. Market Insights By Usage
9. Market Insights By Distribution Channel
10. Market Insights By Countries
11. Value Chain Analysis
12. Competitive Landscape
13. Company Profiled
14. Acronyms & Assumption
15. Annexure
Analyzing the historical market, estimating the current market, and forecasting the future market of the MENA Syringes & Cannula market were the three major steps undertaken to create and analyze the adoption of MENA Syringes & Cannula in major regions of MENA. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the MENA Syringes & Cannula market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the MENA Syringes & Cannula market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the MENA Syringes & Cannula market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as product, usage, and distribution channel. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the MENA Syringes & Cannula market. Further, we conducted factor analysis using dependent and independent variables such as product, usage, and distribution channel of the MENA Syringes & Cannula market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the MENA Syringes & Cannula market sector across the globe.
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the MENA Syringes & Cannula market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2032 for different segments and sub-segments across the major markets of MENA. The research methodology adopted to estimate the market size encompasses:
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Market Engineering
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the MENA Syringes & Cannula market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of the product, usage, distribution channel in the MENA Syringes & Cannula market.
The current & future market trends of the MENA Syringes & Cannula market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
Q1: What is the current market size and growth potential of the MENA Syringes & Cannula market?
Q2: What are the driving factors for the growth of the MENA Syringes & Cannula market?
Q3: Which segment has the largest MENA Syringes & Cannula market share by usage?
Q4: What are the trends in the MENA Syringes & Cannula market?
Q5: Which region will dominate the MENA Syringes & Cannula market?
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
